Cardiovascular health in pediatric heart transplant patients.
Cardiometabolic
Cardiovascular health
Heart transplant
Pediatric
Journal
BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539
Informations de publication
Date de publication:
01 04 2022
01 04 2022
Historique:
received:
17
02
2021
accepted:
21
03
2022
entrez:
2
4
2022
pubmed:
3
4
2022
medline:
6
4
2022
Statut:
epublish
Résumé
Ideal "cardiovascular health" (CVH)-optimal diet, exercise, nonsmoking, BMI, BP, lipids, and glucose-is associated with healthy longevity in adults. Pediatric heart transplant (HT) patients may be at risk for suboptimal CVH. Single-center retrospective study of HT patients 2003-2014 who survived 1 year post-transplant. Five CVH metrics were collected at listing, 1, 3 and 5 years post-transplant (diet and exercise were unavailable). CVH was scored by summing individual metrics: ideal = 2, intermediate = 1, and poor = 0 points; total scores of 8-10 points were considered high (favorable). CVH was compared between HT patients and the US pediatric population (GP) utilizing NHANES 2007-2016. Logistic regression was performed to examine the association of CVH 1 year post-transplant with a composite adverse outcome (death, re-listing, coronary vasculopathy, or chronic kidney disease) 3 years post-transplant. We included 110 HT patients (median age at HT: 6 years [range 0.1-21]) and 19,081 NHANES participants. CVH scores among HT patients were generally high at listing (75%), 1 (74%), 3 (87%) and 5 (76%) years post-transplant and similar to GP, but some metrics (e.g., glucose) were worse among HT patients. Among HT patients, CVH was poorer with older age and non-Caucasian race/ethnicity. Per 1-point higher CVH score, the demographic-adjusted OR for adverse outcomes was 0.95 (95% CI, 0.7-1.4). HT patients had generally favorable CVH, but some metrics were unfavorable and CVH varied by age and race/ethnicity. No significant association was detected between CVH and adverse outcomes in this small sample, but study in a larger sample is warranted.
Sections du résumé
BACKGROUND
Ideal "cardiovascular health" (CVH)-optimal diet, exercise, nonsmoking, BMI, BP, lipids, and glucose-is associated with healthy longevity in adults. Pediatric heart transplant (HT) patients may be at risk for suboptimal CVH.
METHODS
Single-center retrospective study of HT patients 2003-2014 who survived 1 year post-transplant. Five CVH metrics were collected at listing, 1, 3 and 5 years post-transplant (diet and exercise were unavailable). CVH was scored by summing individual metrics: ideal = 2, intermediate = 1, and poor = 0 points; total scores of 8-10 points were considered high (favorable). CVH was compared between HT patients and the US pediatric population (GP) utilizing NHANES 2007-2016. Logistic regression was performed to examine the association of CVH 1 year post-transplant with a composite adverse outcome (death, re-listing, coronary vasculopathy, or chronic kidney disease) 3 years post-transplant.
RESULTS
We included 110 HT patients (median age at HT: 6 years [range 0.1-21]) and 19,081 NHANES participants. CVH scores among HT patients were generally high at listing (75%), 1 (74%), 3 (87%) and 5 (76%) years post-transplant and similar to GP, but some metrics (e.g., glucose) were worse among HT patients. Among HT patients, CVH was poorer with older age and non-Caucasian race/ethnicity. Per 1-point higher CVH score, the demographic-adjusted OR for adverse outcomes was 0.95 (95% CI, 0.7-1.4).
CONCLUSIONS
HT patients had generally favorable CVH, but some metrics were unfavorable and CVH varied by age and race/ethnicity. No significant association was detected between CVH and adverse outcomes in this small sample, but study in a larger sample is warranted.
Identifiants
pubmed: 35365073
doi: 10.1186/s12872-022-02575-z
pii: 10.1186/s12872-022-02575-z
pmc: PMC8973961
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
139Informations de copyright
© 2022. The Author(s).
Références
J Am Coll Cardiol. 2015 Aug 4;66(5):547-57
pubmed: 26227194
Congenit Heart Dis. 2012 Jul-Aug;7(4):324-35
pubmed: 22613206
J Heart Lung Transplant. 2006 Oct;25(10):1192-8
pubmed: 17045931
Pediatr Transplant. 2007 Aug;11(5):459-60
pubmed: 17631010
J Heart Lung Transplant. 2018 Oct;37(10):1184-1195
pubmed: 30293614
J Am Coll Cardiol. 2001 Jul;38(1):206-13
pubmed: 11451276
J Am Heart Assoc. 2018 May 17;7(11):
pubmed: 29773573
JAMA Netw Open. 2019 May 3;2(5):e194758
pubmed: 31150075
Circulation. 2010 Apr 20;121(15):1768-77
pubmed: 20404268
Circulation. 2001 May 1;103(17):2144-52
pubmed: 11331254
Pediatr Transplant. 2011 Nov;15(7):699-705
pubmed: 22004544
PLoS One. 2015 Jul 08;10(7):e0131537
pubmed: 26154254
J Heart Lung Transplant. 2019 Jan;38(1):102-103
pubmed: 30563620
Pediatr Transplant. 2000 Aug;4(3):193-9
pubmed: 10933319
Pediatr Transplant. 2018 Mar;22(2):
pubmed: 29377429
J Heart Lung Transplant. 2005 Jun;24(6):645-51
pubmed: 15949722
Circulation. 2017 May 2;135(18):1693-1701
pubmed: 28461414
J Heart Lung Transplant. 2006 Oct;25(10):1199-205
pubmed: 17045932
Circulation. 2014 Nov 4;130(19):1676-83
pubmed: 25274000
Pediatr Transplant. 2019 Feb;23(1):e13316
pubmed: 30393915
Pediatr Transplant. 2016 Nov;20(7):963-969
pubmed: 27421915
Circulation. 2012 May 29;125(21):2595-602
pubmed: 22547667
Prev Med. 2019 Feb;119:87-98
pubmed: 30594534
J Biomed Inform. 2016 Apr;60:95-103
pubmed: 26828957
J Heart Lung Transplant. 2012 Sep;31(9):1003-8
pubmed: 22789135
Pediatr Transplant. 2005 Aug;9(4):523-30
pubmed: 16048607
J Heart Lung Transplant. 2009 Dec;28(12):1273-8
pubmed: 19783177
Am J Transplant. 2003 Aug;3(8):994-8
pubmed: 12859535
Am J Kidney Dis. 2016 Aug;68(2):212-218
pubmed: 26970941
N Engl J Med. 2003 Sep 4;349(10):931-40
pubmed: 12954741
Circulation. 2010 Feb 2;121(4):586-613
pubmed: 20089546
J Heart Lung Transplant. 2004 Mar;23(3):317-22
pubmed: 15019641
Ann Thorac Surg. 2014 Dec;98(6):2145-50; discussion 2150-1
pubmed: 25443019
J Heart Lung Transplant. 2001 Feb;20(2):230
pubmed: 11250439
Transplant Proc. 2011 Jul-Aug;43(6):2257-9
pubmed: 21839250
JAMA. 2016 Jun 7;315(21):2292-9
pubmed: 27272581